Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 5Breast Neoplasms 3Urinary Bladder Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Prostatic Neoplasms 2Cardiovascular Diseases 2Triple Negative Breast Neoplasms 1Prostatic Intraepithelial Neoplasia 1Osteoporosis 1Neuralgia 1Hematologic Neoplasms 1Head and Neck Neoplasms 1Fatigue 1Eye Diseases 1Colorectal Neoplasms 1Cognitive Dysfunction 1Breast Neoplasms, Male 1Bone Diseases, Metabolic 1

Interventions

Lidocaine 4Oxycodone 2Capsaicin 2ziconotide 1nabiximols 1Vitamin B 6 1Vitamin B 12 1Vinorelbine 1Vincristine 1Transcutaneous Electric Nerve Stimulation 1Transcranial Magnetic Stimulation 1Thalidomide 1Telmisartan 1Tapentadol 1Surveys and Questionnaires 1Sodium Chloride 1Pregabalin 1Plastic Surgery Procedures 1Paclitaxel 1Oxaliplatin 1Morphine 1Methadone 1Manipulation, Osteopathic 1Lidoderm 1Ketamine 1KRN 5500 1Hypnosis 1Hydromorphone 1Geritol 1Gabapentin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Neuralgia × Geritol × Clear all
NCT00659269 2016-02-26

A Randomized Phase III Study of Vitamins B6 and B12 to Prevent Chemotherapy-Induced Neuropathy in Cancer Patients

New Mexico Cancer Research Alliance

Phase 3 Completed
319 enrolled 7 charts

Neoplasms, Neuralgia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡